CASE REPORT EVALUATING HYPERTENSION IN YOUNG PATIENTS: A CASE REPORT HIGHLIGHTING THE NEED TO CONSIDER PARAGANGLIOMA
Main Article Content
Keywords
Paraganglioma, Hypertension, Catecholamines, Neuroendocrine tumor, Panic attacks
Abstract
Paragangliomas are rare neuroendocrine tumors that secrete catecholamines thus leading to hypertension and tachycardia. This is because paragangliomas in young patients may manifest symptoms that are periodic and thus may be confused with other diseases such as panic disorders and primary hypertension. This case report presents a 17-year-old boy who was diagnosed with hypertension, palpitations, and severe panic attacks for the last two months. He was not a steady candidate of constant blood pressure throughout the day and he had many cases of tachycardia. Biochemical investigations revealed elevated plasma normetanephrine levels suggesting the presence of a catecholamine-producing tumour. These were further supported by a 24-hour urine test which came out higher than the normal range of urinary normetanephrine level. Follow-up MRI and PET-CT scans showed neck lesions in close apposition to the carotid artery but there was no evidence of metastatic disease. Therefore the diagnosis of paraganglioma was made and the patient was scheduled for surgical removal of the tumours. This case emphasizes the diagnostic challenges in patients with paraganglioma especially when they are young and present with episodic hypertension and panic-like symptoms. Both biochemical and imaging studies should be implemented during the first stage of the disease to prevent complications such as hypertensive crises or tumor metastasis and to give adequate treatment.
References
2. Buffet, A., Ben Aim, L., Leboulleux, S., Drui, D., Vezzosi, D., Libé, R., ... & French Group of Endocrine Tumors (GTE) and COMETE Network. (2019). Positive impact of genetic tests on the management and outcome of patients with paraganglioma and/or pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism, 104(4), 1109-1118.
3. Calhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., ... & Carey, R. M. (2008). Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension, 51(6), 1403-1419.
4. Eisenhofer, G., & Peitzsch, M. (2014). Laboratory evaluation of pheochromocytoma and paraganglioma. Clinical chemistry, 60(12), 1486-1499.
5. Fishbein, L., Leshchiner, I., Walter, V., Danilova, L., Robertson, A. G., Johnson, A. R., ... & Roach, J. (2017). Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer cell, 31(2), 181-193.
6. Jain, A., Baracco, R., & Kapur, G. (2020). Pheochromocytoma and paraganglioma—an update on diagnosis, evaluation, and management. Pediatric Nephrology, 35, 581-594.
7. Lenders, J. W., Duh, Q. Y., Eisenhofer, G., Gimenez-Roqueplo, A. P., Grebe, S. K., Murad, M. H., ... & Young Jr, W. F. (2014). Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 99(6), 1915-1942.
8. Ma, X., Chen, Z., Xia, P., Zhang, C., Yan, K., Fan, Y., ... & Bu, P. (2022). Giant paraganglioma complicated with catecholamine crisis and catecholamine cardiomyopathy: a case report and review of the literature. Frontiers in Endocrinology, 12, 790080.
9. Pacak, K. (2022). New biology of pheochromocytoma and paraganglioma. Endocrine Practice, 28(12), 1253-1269.
10. Schmittinger, C. A., Torgersen, C., Luckner, G., Schröder, D. C., Lorenz, I., & Dünser, M. W. (2012). Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive care medicine, 38, 950-958.
11. Sharma, S., & Fishbein, L. (2023). Diagnosis and management of pheochromocytomas and paragangliomas: A guide for the clinician. Endocrine Practice.
12. Shen, Y., Zhong, Y., Wang, H., Ma, L., Wang, Y., Zhang, K., ... & Ye, H. (2018). MR imaging features of benign retroperitoneal paragangliomas and schwannomas. BMC neurology, 18, 1-8.
13. Siddiqui, N., Daya, R., Seedat, F., Bulbulia, S., & Bayat, Z. (2021). Secondary hypertension: An update on the diagnosis and localisation of a pheochromocytoma or paraganglioma. South African Family Practice, 63(3).
14. Tanabe, A., & Naruse, M. (2020). Recent advances in the management of pheochromocytoma and paraganglioma. Hypertension Research, 43(11), 1141-1151.
15. Y-Hassan, S., & Falhammar, H. (2020). Cardiovascular manifestations and complications of pheochromocytomas and paragangliomas. Journal of clinical medicine, 9(8), 2435.
16. Young, F. W., & Wen, P. Y. (2023). Paragangliomas: epidemiology, clinical presentation, diagnosis, and histology. UpToDate, Waltham.
17. Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., ... & Cho, B. (2017). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants. The Lancet, 389(10064), 37-55.
18. Çetin Ş, Kir G, Yilmaz M. Thyroid Paraganglioma Diagnosed by Fine-Needle Aspiration Biopsy, Correlated With Histopathological Findings: Report of a Case. Diagn Cytopathol. 2016 Jul;44(7):643-7. doi: 10.1002/dc.23496. Epub 2016 May 10. PMID: 27162199.
19. Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, Adams KT, Wolf KI, Herscovitch P, Fojo AT, Buchmann I, Kebebew E, Pacak K. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1784-91. doi: 10.1007/s00259-016-3357-x. Epub 2016 Mar 21. PMID: 26996779; PMCID: PMC8194362.
20. Oyenusi EE, Nwigbo UF, Oladipo OM, Kene-Udemezue BE, Akowundu KP, Oleolo-Ayodeji KO, Afoke OA, Babatunde FO, Alakaloko FM, Asiyanbi GK, Ogunleye EO, Oduwole AO, Lesi FEA. An Atypical Presentation of Childhood Paraganglioma with Seizures: A Case Report and Review of the Literature. Case Rep Endocrinol. 2023 Nov 27;2023:6637802. doi: 10.1155/2023/6637802. PMID: 38058957; PMCID: PMC10696474.
21. Reus X, Vicens C, García-Serra C. Young woman diagnosed with paraganglioma in primary care. BMJ Case Rep. 2021 Jul 21;14(7):e242448. doi: 10.1136/bcr-2021-242448. PMID: 34290011; PMCID: PMC8296784.
22. Rahman MA, Venkataram T, Habib R, Jahan N, Raihan F, Alam S, Mahmood E, Umana GE, Chaurasia B. Synchronous Carotid Body and Glomus Jugulare Tumors : A Case Report and Review of Literature. J Korean Neurosurg Soc. 2024 Jan;67(1):122-129. doi: 10.3340/jkns.2022.0273. Epub 2023 Aug 30. PMID: 37643721; PMCID: PMC10788546.
23. Kawanabe S, Katabami T, Oshima R, Yanagisawa N, Sone M, Kimura N. A rare case of multiple paragangliomas in the head and neck, retroperitoneum and duodenum: A case report and review of the literature. Front Endocrinol (Lausanne). 2023 Jan 10;13:1054468. doi: 10.3389/fendo.2022.1054468. PMID: 36704041; PMCID: PMC9871575.